Sign in
CompletedNo phase

Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis

Key facts

Who runs it
Queen Mary University of London
Where
United Kingdom2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
130 people enrolled
Started
11 Nov 2021
Ended
31 Dec 2025
Type of study
Observational, 2 groups
Record updated
2 March 2026

Who can take part

Age
18 years to 120 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Adult (≥ 18 years)
  • Patients with a probable (50-90% likelihood) or highly probable (>90% likelihood) diagnosis of cardiac sarcoidosis (CS) by a multidisciplinary team meeting in a CS-specialist centre as per the WASOG criteria
  • Patients attending outpatient clinics in a CS-specialist centre

Who cannot take part

  • Unable or unwilling to give informed consent
  • Unable or unwilling to give and/or complete the study questionnaires • Inability to understand written and/or verbal English

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

What is the purpose of this research?

Read full original descriptionShow less

This study includes two parts based in two NHS specialist centres for cardiac sarcoidosis:

* Development of the CARD-SARC: Development of the new questionnaire to measure quality of life in cardiac sarcoidosis patients (the CARD-SARC questionnaire) * Validation of the CARD-SARC: Evaluation of how good the CARD-SARC questionnaire is at measuring quality of life changes in patients with cardiac sarcoidosis.

The 2 groups in the trial

  • Development of the CARD-SARC (n=20)

    * Interviews: 6-20 participants (depending of data saturation) will be recruited using a convenience sampling strategy. * Field-testing: 20 participants using a convenience/consecutive sampling strategy.

  • Validation of the CARD-SARC (n=100)

    The CS-specialist centres (Barts Health NHS Trust and Royal Papworth Hospital NHS Foundation Trust) have a cohort of 60-70 potential candidates in each site. The estimated sample size for the Pilot-testing is 100 study participants, considering previous sarcoidosis studies including PROMs, with less than 10% population declining participation or failing to complete their questionnaires.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
2 March 2026